Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/19/23 → 10/31/25 |
Funding
- Janssen Research and Development LLC: $21,940.00
A Randomized, Doubleblind, Multicenter, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with...
- Dubovsky, Steven (PI)
Project: Research